You are here

Beyond remission and mucosal healing in Crohn’s disease. Exploring the deep with cross sectional imaging

Digestive and Liver Disease, May 2017, Volume 49, Issue 5, Pages 457-458


The targets of therapy in inflammatory bowel disease (IBD) have changed in recent years. A growing body of evidence has shown that biologics allow treating beyond the symptoms, making healing of the mucosa of the damaged bowel the new goal of therapy [1]. Endoscopic mucosal healing (MH) is associated with a stable steroid-free remission, a longer time to relapse after drug withdrawal and a lower rate of hospitalizations and surgery [1,2].